查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423344

2024-2032 年按產品（激素子宮內避孕器、含銅子宮內避孕器）、最終用途（醫院、婦科診所、社區醫療保健等）和地區分類的子宮內避孕器 (IUD) 市場報告

Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球子宮內避孕器市場規模達到45億美元。展望未來， IMARC Group預計到2032年市場規模將達到66億美元，2024-2032年複合年成長率（CAGR）為4.1%。有效、長期避孕方法的出現促進了人們對生殖健康的認知不斷提高、人口控制努力的不斷增加以及醫療技術和研究的不斷進步，這些都是推動市場發展的一些因素。

子宮內避孕器 (IUD) 是一種長期、可逆的節育方式，是當今最有效的避孕方法之一。子宮內避孕器是一種小型 T 形裝置，由醫療保健提供者插入子宮以防止懷孕。子宮內避孕器主要有兩種類型：銅子宮內避孕器，它釋放少量的銅以阻止精子到達卵子；荷爾蒙子宮內避孕器，它釋放激素使子宮頸黏液變稠並阻止精子與卵子受精。子宮內避孕器提供較長的保護期，從三年到十年不等，具體取決於類型。它們提供了最少的持續護理的便利，並因其功效、可逆性和易用性而受到青睞。

全球市場的主要促進因素是人們對生殖健康的認知不斷提高，而有效、長期的避孕方法的可用性促進了這種認知的提高。與此一致的是，人們對可逆且無麻煩的節育選擇的日益偏好也為市場提供了動力。此外，醫療保健提供者和組織對子宮內避孕器的好處和使用的支持和教育舉措正在成為市場成長的重要誘導因素。除此之外，子宮內避孕器因其安全性和可靠性而受到醫療專業人員的認可，正在鼓勵市場的擴大。此外，政府促進計劃生育和生殖健康教育的措施的增加也對市場產生了積極影響。有利的醫療保健政策和保險範圍進一步推動了市場的發展，這使得子宮內避孕器對於更廣泛的人群來說更容易獲得和負擔得起。

子宮內避孕器 (IUD) 市場趨勢/促進因素：

人口控制力道呈上升趨勢

人們對永續發展的認知不斷增強，促使各國政府和國際組織優先考慮人口控制工作。政策方向的這一重大轉變正在加強子宮內避孕器等有效且長期的避孕方法的作用。此外，一些國家的政府機構、非政府組織和製造商之間的各種合作計劃旨在推廣子宮內避孕器作為計劃生育的首選方法。這些聯盟通常會帶來廣泛的活動、分銷網路和教育推廣，使子宮內避孕器更容易為不同人群所使用和接受。此外，各地區的針對性干預措施和補助進一步促進了子宮內避孕器的採用。全球人口控制運動強調負責任的計劃生育和生殖選擇，是子宮內避孕器市場的強大驅動力，刺激了需求和創新。

女性勞動參與度不斷提高

女性勞動參與度的上升標誌著文化和經濟的轉變，影響著生活的各個層面，包括生育選擇。隨著女性繼續承擔職業角色，對方便、可靠和低維護的避孕方法的需求不斷成長。子宮內避孕器以其延長的有效性和最少的持續護理而聞名，符合職業婦女的生活方式需求。它們提供了許多人在平衡職業和個人生活時所尋求的靈活性和保證。此外，雇主和醫療保健提供者越來越認知到這些需求，為子宮內避孕器提供支援和承保，作為全面健康福利的一部分。市場供應與日益成長的人口的現實生活需求的結合不僅是一種趨勢，而且是子宮內避孕器市場的重要推動力。

醫療技術和研究的不斷進步

醫療保健產業的特點是醫療技術和研究不斷進步，避孕領域也不例外。材料、設計和荷爾蒙輸送機制的創新促進了更先進和方便用戶使用的子宮內避孕器的開發。該領域領先公司通常與醫療保健提供者和研究機構合作，對研發的投資推動了改進的動力。這些合作關係使我們能夠更深入地了解使用者的需求、偏好和醫療要求，並指導新子宮內避孕器型號的設計和功能。對創新的關注確保子宮內避孕器始終處於避孕技術的前沿，提供不僅有效且符合使用者舒適度和福祉的選擇。對技術進步的投資強調了對加強生殖健康的承諾，使其成為子宮內避孕器市場成長的關鍵驅動力。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球子宮內避孕器市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：按產品
  • 市場區隔：最終用途別
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 概述
    • 研究與開發
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第 6 章：市場區隔：依產品

  • 荷爾蒙子宮內避孕器
    • 市場走向
    • 市場預測
  • 銅子宮內避孕器
    • 市場走向
    • 市場預測

第 7 章：市場區隔：最終用途別

  • 醫院
    • 市場走向
    • 市場預測
  • 婦科診所
    • 市場走向
    • 市場預測
  • 社區醫療
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 歐洲
    • 市場走向
    • 市場預測
  • 北美洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 9 章：子宮內避孕器製造流程

  • 產品概述
  • 原料要求
  • 製造流程
  • 關鍵成功因素與風險因素

第 10 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Actavis
    • Bayer
    • Teva Pharmaceuticals
    • Allergan
    • ANI Pharmaceuticals
    • Eurogine
    • OCON Medical
    • Pregna
    • SMB Corporation
    • HLL Lifecare
    • HRA Pharma
    • Besins HealthCare
Product Code: SR112024A954

Abstract

The global intrauterine devices market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods, the rising trend of population control efforts, and continual advancements in medical technology and research represent some of the factors that are propelling the market.

Intrauterine Devices (IUDs) are a form of long-term, reversible birth control, representing one of the most effective contraceptive methods available today. An IUD is a small, T-shaped device that is inserted into the uterus by a healthcare provider to prevent pregnancy. There are two main types of IUDs: copper IUDs, which release a small amount of copper to deter sperm from reaching the egg, and hormonal IUDs, which release hormones to thicken cervical mucus and block sperm from fertilizing the egg. IUDs provide an extended period of protection, ranging from three to ten years, depending on the type. They offer the convenience of minimal ongoing care and are favored for their efficacy, reversibility, and ease of use.

The global market is primarily driven by the increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods. In line with this, the growing preference for reversible and hassle-free birth control options is also providing an impetus to the market. Moreover, the support and educational initiatives by healthcare providers and organizations about the benefits and usage of IUDs are acting as significant growth-inducing factors for the market. In addition to this, the endorsement of IUDs by medical professionals, owing to their safety and reliability, is encouraging the expansion of the market. Also, the rise in government initiatives promoting family planning and reproductive health education is impacting the market positively. The market is further driven by favorable healthcare policies and insurance coverage, which make IUDs more accessible and affordable to a broader population.

Intrauterine Devices (IUD) Market Trends/Drivers:

Rising trend of population control efforts

The growing awareness of sustainable development has led governments and international organizations to prioritize population control efforts. This significant shift in policy direction is reinforcing the role of effective and long-term contraceptive methods such as IUDs. Also, various collaborative programs among governmental bodies of several countries, NGOs, and manufacturers aim to promote IUDs as a preferred method of family planning. These alliances often result in extensive campaigns, distribution networks, and educational outreach, making IUDs more accessible and acceptable to diverse populations. Additionally, tailored interventions and subsidies in various regions further facilitate the adoption of IUDs. This global movement towards population control, with an emphasis on responsible family planning and reproductive choices, stands as a powerful driver for the IUD market, fueling both demand and innovation.

Growing female workforce participation

The rise in the female workforce's participation marks a cultural and economic shift, influencing various aspects of life, including reproductive choices. As women continue to take on professional roles, the need for convenient, reliable, and low-maintenance contraceptive methods has grown. IUDs, known for their extended effectiveness and minimal ongoing care, resonate with the lifestyle needs of working women. They provide the flexibility and assurance that many seek in balancing their careers and personal lives. Moreover, employers and healthcare providers are increasingly recognizing these needs, offering support and coverage for IUDs as part of comprehensive health benefits. This alignment of market supply with the real-life demands of a growing segment of the population is not just a trend but a substantial driving force in the IUD market.

Continual advancements in medical technology and research

The healthcare industry is marked by continuous advancements in medical technology and research, and the field of contraception is no exception. Innovations in materials, designs, and hormone delivery mechanisms have led to the development of more advanced and user-friendly IUDs. The drive for improvement is fueled by investment in research and development by leading companies in the field, often in collaboration with healthcare providers and research institutions. These partnerships enable a deeper understanding of user needs, preferences, and medical requirements, guiding the design and functionality of new IUD models. This focus on innovation ensures that IUDs remain at the forefront of contraceptive technology, offering choices that are not only effective but also aligned with the comfort and well-being of users. The investment in technological progress underscores the commitment to enhancing reproductive health, making it a pivotal driver in the IUD market growth.

Intrauterine Devices (IUD) Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intrauterine devices market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and end-use.

Breakup by Product:

Hormonal Intrauterine Device

Copper Intrauterine Device

Hormonal intrauterine device (IUD) represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes hormonal intrauterine device, and copper intrauterine device. According to the report, hormonal intrauterine devices (IUD) represented the largest segment.

The demand for hormonal IUDs is growing due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many. Their suitability for extended usage of up to 3-7 years offers long-term solutions without the need for daily intervention. The ability to return to normal fertility after removal adds to their appeal. Many users also find them to be a preferable non-surgical option, contributing to their popularity. The combined factors of effectiveness, longevity, reversibility, and non-surgical nature make this segment an integral part of the global IUD market.

On the other hand, copper IUDs offer a contraceptive method without the use of hormones, appealing to those who want to avoid hormonal intervention. They provide a cost-effective solution, often entailing only a one-time expense. The protection they offer is long-lasting, often effective for up to 10 years, making them an attractive long-term option. These factors together make copper IUDs a significant segment, reflecting the various preferences and financial considerations of the global population.

Breakup by End-Use:

Hospitals

Gynaecology Clinics

Community Healthcare

Others

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals, gynaecology clinics, community healthcare, others.

In the hospitals segment, the availability of specialized professionals ensures access to expert care, while the use of modern tools and technologies facilitates insertion. Comprehensive services, including consultation, insertion, and follow-up, create a streamlined patient experience. Hospitals continue to be a core setting for IUD administration, integrating specialized care with state-of-the-art technology to serve a broad population base.

On the other hand, gynaecology clinics are seeing growth in IUD administrations owing to their focused expertise in women's reproductive health. They offer personalized care tailored to individual needs and are often more accessible than hospitals for many patients. This specialized, accessible, and personalized care makes gynaecology clinics an essential part of the landscape, serving a diverse clientele with varying needs and preferences.

Furthermore, community healthcare segment of the market is impelled by the introduction of affordable and often lower-cost services. Accessibility in remote and underserved areas ensures that more people can avail themselves of these devices. Education and outreach are significant components of this segment, with community health providers offering necessary information and support. This approach fosters a wider reach and makes IUDs available to populations that might otherwise have limited access.

Breakup by Region:

Europe

North America

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest intrauterine devices (IUD) market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The North America region's IUD market is driven by several factors, forming a complex and synergistic landscape that fosters growth. The well-developed healthcare infrastructure ensures robust availability and service delivery, making both hormonal and copper IUDs accessible to a wide range of the population.

Regulatory support in this region fosters a generally favorable environment for IUDs, with clear guidelines and standards that help maintain quality and safety. Economic factors, particularly higher income levels, facilitate more accessible healthcare services, allowing for a broader spectrum of the population to avail themselves of this contraceptive method. These financial considerations also support ongoing research and development in the field, leading to potential innovations and improvements in IUD technology.

The positively changing cultural attitudes towards reproductive health is contributing to a more open dialogue and acceptance of various contraceptive options, including IUDs. The integration of advanced medical practices and continual professional development among healthcare providers further enhances the region's ability to offer state-of-the-art care.

Competitive Landscape:

The leading companies are investing in research and development (R&D) activities to create new and improved IUDs. These innovations often focus on enhancing effectiveness, reducing side effects, and increasing user comfort. The key players are also exploring new markets and expanding into emerging economies to utilize opportunities in areas where contraceptive methods like IUDs may be less prevalent. To enhance awareness and acceptance of IUDs, the major companies are engaging in educational campaigns by working with healthcare providers and community organizations to provide accurate product information. Furthermore, the top players are working closely with regulatory bodies to ensure that their products comply with local laws and guidelines, maintaining quality and safety. Apart from this, they are also diversifying their portfolio and offering products at various price points, to make IUDs accessible to a broader range of income levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Actavis

Bayer

Teva Pharmaceuticals

Allergan

ANI Pharmaceuticals

Eurogine

OCON Medical

Pregna

SMB Corporation

HLL Lifecare

HRA Pharma

Besins HealthCare

Recent Developments:

In June 2023, Teva Pharmaceuticals and Alvotech announced they have reached a settlement and license agreement with Johnson & Johnson concerning AVT04, a biosimilar to Stelara agreement in the United States. The settlement grants a license entry date for AVT04 in the United States around February 21, 2025.

In Aril 2021, OCON Medical earned the 2021 Global Enabling Technology Leadership Award from Frost & Sullivan for creating the world's first 3D spherical copper IUD, the Intra Uterine Ball (IUB) Ballerine. Crafted from nitinol, this innovative IUD not only ensures shape retention but also holds potential as a drug transporter for uterine health treatments.

In June 2023, Pregna International Ltd announced that the company has raised its first private equity funding of $16 million or Rs130 crore from India Life Sciences Fund III (ILSF III) for a minority stake.

Key Questions Answered in This Report

  • 1. What was the size of the global intrauterine devices market in 2023?
  • 2. What is the expected growth rate of the global intrauterine devices market during 2024-2032?
  • 3. What are the key factors driving the global intrauterine devices market?
  • 4. What has been the impact of COVID-19 on the global intrauterine devices market?
  • 5. What is the breakup of the global intrauterine devices market based on the product?
  • 6. What are the key regions in the global intrauterine devices market?
  • 7. Who are the key players/companies in the global intrauterine devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intrauterine Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by End-Use
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Hormonal Intrauterine Device
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Copper Intrauterine Device
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by End-Use

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gynaecology Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Community Healthcare
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 North America
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intrauterine Devices Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Actavis
    • 10.3.2 Bayer
    • 10.3.3 Teva Pharmaceuticals
    • 10.3.4 Allergan
    • 10.3.5 ANI Pharmaceuticals
    • 10.3.6 Eurogine
    • 10.3.7 OCON Medical
    • 10.3.8 Pregna
    • 10.3.9 SMB Corporation
    • 10.3.10 HLL Lifecare
    • 10.3.11 HRA Pharma
    • 10.3.12 Besins HealthCare

List of Figures

  • Figure 1: Global: Intrauterine Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Intrauterine Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intrauterine Devices Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Intrauterine Devices Market: Breakup by End-Use (in %), 2023
  • Figure 5: Global: Intrauterine Devices Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Intrauterine Devices Industry: SWOT Analysis
  • Figure 8: Global: Intrauterine Devices Industry: Value Chain Analysis
  • Figure 9: Global: Intrauterine Devices Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intrauterine Devices (Hormonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intrauterine Devices (Hormonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intrauterine Devices (Copper) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intrauterine Devices (Copper) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intrauterine Devices (End-Use in Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intrauterine Devices (End-Use in Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intrauterine Devices (End-Use in Community Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intrauterine Devices (End-Use in Community Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intrauterine Devices (Other End-Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intrauterine Devices (Other End-Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Europe: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Europe: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Asia Pacific: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Asia Pacific: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Latin America: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Latin America: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Intrauterine Devices Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intrauterine Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Intrauterine Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Intrauterine Devices Market Forecast: Breakup by End-Use (in Million US$), 2024-2032
  • Table 4: Global: Intrauterine Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Intrauterine Devices Manufacturing: Raw Material Requirements
  • Table 6: Global: Intrauterine Devices Market: Competitive Structure
  • Table 7: Global: Intrauterine Devices Market: Key Players